Recurrent WHO Grade II Glioma

specific

The reemergence of WHO grade 2 glioma after a period of remission.

11

Centers

5

Active Trials

—

Cancer Funding

Top Centers for Recurrent WHO Grade II Glioma(11)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
Active Research Program
66.8
2
Yale Cancer Center Yale School of MedicineNew Haven, CT
NCI Comprehensive
Active Research Program
66.8
3
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
66.8
4
Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN
NCI Comprehensive
Active Research Program
66.8
5
Boston University Cancer CenterBoston, MA
Active Research Program
66.8
6
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
44.3
7
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD
NCI Comprehensive
44.3
8
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
44.3
9
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
44.3
10
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
44.3
11
Cleveland Clinic Cancer CenterCleveland, OH
44.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →